StonvexLoading…
StonvexStonvexStonvexCore line items from ARIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $927.66M | $510.60M | $447.67M | $399.96M |
Operating Income | $359.37M | $117.44M | $108.83M | $61.49M |
Net Income | $79.37M | $23.29M | $11.42M | $-4.86M |
EPS (Diluted) | $0.41 | $0.14 | $0.08 | $-0.25 |
Total Assets | $2.51B | $1.99B | $1.35B | $1.24B |
Total Liabilities | $1.06B | $911.40M | $728.22M | $746.23M |
Cash & Equivalents | $391.87M | $252.53M | $194.62M | $299.46M |
Free Cash Flow OCF − CapEx | $129.07M | $-40.21M | $-9.02M | $-38.09M |
Shares Outstanding | 205.53M | 171.03M | 137.57M | 136.06M |